In gastric cancer, RPRD1B can adjust the intake and synthesis of fatty acids through the upregulation of c-Fos/c-Jun, and c-Fos/c-Jun can also decrease the degradation of RPRD1B by increasing the content of the lncRNA NEAT (18). Here, FOS is linked to gastric cancer.